FDA Inspection 1325794 — Vitalant
The FDA completed an inspection of Vitalant on June 26, 2026 in San Mateo, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 26, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Mateo, CA (United States)